drugset
Drugs / Covifenz
last change Aug 2025 re-read 2 minutes ago

Covifenz

also known as Medicago Covifenz

Vaccine

Developed for
COVID-19
Investigated by
BC Children's Hospital Research Institute · CHU de Quebec-Universite Laval · Canadian Center for Vaccinology · Canadian Immunization Research Network · Children's Hospital Research Institute of Manitoba · Interior Health
+5 more · Massachusetts General Hospital · McGill University Health Centre/Research Institute of the McGill University Health Centre · Ontario Agency for Health Protection and Promotion · Ottawa Hospital Research Institute · University of Toronto

Trials 1 · a red edge is where a trial was stopped

today NCT04894435 · Ph 2
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04894435 May 2021 → Nov 2024 overdue COVID-19 Canadian Immunization Research Network Active not recruiting No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Covifenz ClinicalTrials.gov intervention name — accepted as the source's own label NCT04894435 ↗
Known as Medicago Covifenz “For dose 3, the currently available mRNA vaccines (Pfizer-BioNTech BNT162b2 and Moderna mRNA-1273) and plant-based virus-like particle (Medicago Covifenz) are anticipated to be...” NCT04894435 ↗
Modality Vaccine “Covifenz vaccine” NCT04894435 ↗
Route Intramuscular “Covifenz vaccine via intramuscular injection in the deltoid muscle” NCT04894435 ↗